337 related articles for article (PubMed ID: 32473632)
21. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
[TBL] [Abstract][Full Text] [Related]
22. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
[TBL] [Abstract][Full Text] [Related]
23. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation.
Wang J; Su G; Yin X; Luo J; Gu R; Wang S; Feng J; Chen B
Biomed Pharmacother; 2019 Dec; 120():109493. PubMed ID: 31586902
[TBL] [Abstract][Full Text] [Related]
24. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
[TBL] [Abstract][Full Text] [Related]
25. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.
Sun HP; Su JH; Meng QS; Yin Q; Zhang ZW; Yu HJ; Zhang PC; Wang SL; Li YP
Acta Pharmacol Sin; 2016 Jul; 37(7):941-9. PubMed ID: 27133295
[TBL] [Abstract][Full Text] [Related]
26. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
27. Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis.
Xiaoxia X; Jing S; Dongbin X; Yonggang T; Jingke Z; Yanying Z; Hulai W
Curr Drug Deliv; 2020; 17(2):148-158. PubMed ID: 31939730
[TBL] [Abstract][Full Text] [Related]
28. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
29. Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer.
Forghani P; Khorramizadeh MR; Waller EK
Cancer Med; 2014 Apr; 3(2):215-24. PubMed ID: 24574320
[TBL] [Abstract][Full Text] [Related]
30. Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.
Kim S; Han J; Jeon M; You D; Lee J; Kim HJ; Bae S; Nam SJ; Lee JE
Tumour Biol; 2016 Aug; 37(8):11397-407. PubMed ID: 26984157
[TBL] [Abstract][Full Text] [Related]
31. Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
Pei S; Yang X; Wang H; Zhang H; Zhou B; Zhang D; Lin D
BMC Cancer; 2015 Dec; 15():965. PubMed ID: 26674531
[TBL] [Abstract][Full Text] [Related]
32. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
[TBL] [Abstract][Full Text] [Related]
33. Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.
Wan X; Zheng X; Pang X; Pang Z; Zhao J; Zhang Z; Jiang T; Xu W; Zhang Q; Jiang X
Oncotarget; 2016 Jun; 7(23):34038-51. PubMed ID: 27086917
[TBL] [Abstract][Full Text] [Related]
34. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
35. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
36. Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.
Qin JJ; Wang W; Sarkar S; Zhang R
J Control Release; 2016 Sep; 237():101-14. PubMed ID: 27394681
[TBL] [Abstract][Full Text] [Related]
37. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
[TBL] [Abstract][Full Text] [Related]
38. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.
Wang Q; Luo M; Wei N; Chang A; Luo KQ
Mol Pharm; 2019 Sep; 16(9):3873-3886. PubMed ID: 31389706
[TBL] [Abstract][Full Text] [Related]
39. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
40. Regulating the Golgi apparatus by co-delivery of a COX-2 inhibitor and Brefeldin A for suppression of tumor metastasis.
Yu RY; Xing L; Cui PF; Qiao JB; He YJ; Chang X; Zhou TJ; Jin QR; Jiang HL; Xiao Y
Biomater Sci; 2018 Jul; 6(8):2144-2155. PubMed ID: 29923556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
